Cargando…

Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer

BACKGROUND: African-Americans have the highest overall cancer death rate and shortest survival time of any racial or ethnic group in the United States. The most common cancer studied in African-American radiation therapy (RT) access disparities research is breast cancer. The goal of this study is to...

Descripción completa

Detalles Bibliográficos
Autores principales: McClelland, Shearwood, Harris, Eleanor E., Spratt, Daniel E., Cheatham, Chesley, Sun, Yilun, Oliver, Alexandria L., Jaboin, Jerry J., Jagsi, Reshma, Petereit, Daniel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518767/
https://www.ncbi.nlm.nih.gov/pubmed/36186700
http://dx.doi.org/10.5603/RPOR.a2022.0064
_version_ 1784799258924285952
author McClelland, Shearwood
Harris, Eleanor E.
Spratt, Daniel E.
Cheatham, Chesley
Sun, Yilun
Oliver, Alexandria L.
Jaboin, Jerry J.
Jagsi, Reshma
Petereit, Daniel G.
author_facet McClelland, Shearwood
Harris, Eleanor E.
Spratt, Daniel E.
Cheatham, Chesley
Sun, Yilun
Oliver, Alexandria L.
Jaboin, Jerry J.
Jagsi, Reshma
Petereit, Daniel G.
author_sort McClelland, Shearwood
collection PubMed
description BACKGROUND: African-Americans have the highest overall cancer death rate and shortest survival time of any racial or ethnic group in the United States. The most common cancer studied in African-American radiation therapy (RT) access disparities research is breast cancer. The goal of this study is to evaluate the impact of patient navigation on RT access for African-American breast cancer patients. MATERIAL AND METHODS: This study is a prospective survey-based evaluation of the impact of patient navigation on access to hypofractionated RT and financial toxicity in African-American breast cancer patients. The impact of patient navigation on RT access will be collated and analyzed from survey results pre-RT versus post-RT as well as for patients with versus without receipt of patient navigation. The validated COST-Functional Assessment of Chronic Illness Therapy score will be used to compare hypofractionation versus standard fractionated RT financial toxicity for patients with early-stage breast cancer who have received lumpectomy. CONCLUSION: This is the first study to investigate the impact of patient navigation on reducing RT access disparities facing African-American breast cancer patients. The natural progression of this work will be to expand this model to include additional breast cancer populations most vulnerable to suffering RT access disparities (Native American, Hispanic American, Appalachian) within the United States.
format Online
Article
Text
id pubmed-9518767
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-95187672022-09-29 Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer McClelland, Shearwood Harris, Eleanor E. Spratt, Daniel E. Cheatham, Chesley Sun, Yilun Oliver, Alexandria L. Jaboin, Jerry J. Jagsi, Reshma Petereit, Daniel G. Rep Pract Oncol Radiother Letter to the Editor BACKGROUND: African-Americans have the highest overall cancer death rate and shortest survival time of any racial or ethnic group in the United States. The most common cancer studied in African-American radiation therapy (RT) access disparities research is breast cancer. The goal of this study is to evaluate the impact of patient navigation on RT access for African-American breast cancer patients. MATERIAL AND METHODS: This study is a prospective survey-based evaluation of the impact of patient navigation on access to hypofractionated RT and financial toxicity in African-American breast cancer patients. The impact of patient navigation on RT access will be collated and analyzed from survey results pre-RT versus post-RT as well as for patients with versus without receipt of patient navigation. The validated COST-Functional Assessment of Chronic Illness Therapy score will be used to compare hypofractionation versus standard fractionated RT financial toxicity for patients with early-stage breast cancer who have received lumpectomy. CONCLUSION: This is the first study to investigate the impact of patient navigation on reducing RT access disparities facing African-American breast cancer patients. The natural progression of this work will be to expand this model to include additional breast cancer populations most vulnerable to suffering RT access disparities (Native American, Hispanic American, Appalachian) within the United States. Via Medica 2022-07-29 /pmc/articles/PMC9518767/ /pubmed/36186700 http://dx.doi.org/10.5603/RPOR.a2022.0064 Text en © 2022 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
spellingShingle Letter to the Editor
McClelland, Shearwood
Harris, Eleanor E.
Spratt, Daniel E.
Cheatham, Chesley
Sun, Yilun
Oliver, Alexandria L.
Jaboin, Jerry J.
Jagsi, Reshma
Petereit, Daniel G.
Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer
title Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer
title_full Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer
title_fullStr Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer
title_full_unstemmed Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer
title_short Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer
title_sort navigator-assisted hypofractionation (navah) to address radiation therapy access disparities facing african-americans with breast cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518767/
https://www.ncbi.nlm.nih.gov/pubmed/36186700
http://dx.doi.org/10.5603/RPOR.a2022.0064
work_keys_str_mv AT mcclellandshearwood navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer
AT harriseleanore navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer
AT sprattdaniele navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer
AT cheathamchesley navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer
AT sunyilun navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer
AT oliveralexandrial navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer
AT jaboinjerryj navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer
AT jagsireshma navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer
AT petereitdanielg navigatorassistedhypofractionationnavahtoaddressradiationtherapyaccessdisparitiesfacingafricanamericanswithbreastcancer